ATE339521T1 - Verfahren zur bestimmung der expression des dihydropyrimidindehydrogenasegens - Google Patents
Verfahren zur bestimmung der expression des dihydropyrimidindehydrogenasegensInfo
- Publication number
- ATE339521T1 ATE339521T1 AT02704432T AT02704432T ATE339521T1 AT E339521 T1 ATE339521 T1 AT E339521T1 AT 02704432 T AT02704432 T AT 02704432T AT 02704432 T AT02704432 T AT 02704432T AT E339521 T1 ATE339521 T1 AT E339521T1
- Authority
- AT
- Austria
- Prior art keywords
- expression
- determining
- dihydropyrimidine dehydrogenase
- gen
- dehydrogenase gen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/796,807 US6956111B2 (en) | 2001-03-02 | 2001-03-02 | Method of determining dihydropyrimidine dehydrogenase gene expression |
US09/842,111 US6905821B2 (en) | 2001-03-02 | 2001-04-26 | Method of determining Dihydropyrimidine dehydrogenase gene expression |
US09/879,217 US7005278B2 (en) | 2001-03-02 | 2001-06-13 | Method of determining dihydropyrimidine dehydrogenase gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE339521T1 true ATE339521T1 (de) | 2006-10-15 |
Family
ID=27419931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02704432T ATE339521T1 (de) | 2001-03-02 | 2002-02-22 | Verfahren zur bestimmung der expression des dihydropyrimidindehydrogenasegens |
Country Status (15)
Country | Link |
---|---|
US (1) | US7005278B2 (de) |
EP (1) | EP1409723B1 (de) |
JP (1) | JP2005508603A (de) |
CN (1) | CN1250744C (de) |
AR (1) | AR032917A1 (de) |
AT (1) | ATE339521T1 (de) |
AU (1) | AU2002238115B2 (de) |
CA (1) | CA2439313C (de) |
DE (1) | DE60214725T2 (de) |
HK (1) | HK1068375A1 (de) |
IL (1) | IL157694A0 (de) |
MX (1) | MXPA03007884A (de) |
NZ (1) | NZ528374A (de) |
TW (1) | TWI274076B (de) |
WO (1) | WO2002070750A2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020142328A1 (en) | 2000-12-01 | 2002-10-03 | Danenberg Kathleen D. | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
CA2479446C (en) * | 2003-08-28 | 2013-05-07 | F.Hoffmann-La Roche Ag | Correlation of the ratio of tp and dpd mrna expression levels in colorectal cancer with disease-free survival in 5-fu treated patients |
EP3698807A1 (de) | 2005-01-21 | 2020-08-26 | Genentech, Inc. | Fixe dosierung von her-antikörpern |
AU2006216732C1 (en) * | 2005-02-23 | 2017-07-20 | Genentech, Inc. | Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor |
JP2006316040A (ja) | 2005-05-13 | 2006-11-24 | Genentech Inc | Herceptin(登録商標)補助療法 |
US8440398B2 (en) * | 2006-01-25 | 2013-05-14 | Taiho Pharmaceutical Co., Ltd. | Method for prediction of sensitivity to 5-fluorouracil-type anticancer agent |
WO2008109440A2 (en) | 2007-03-02 | 2008-09-12 | Genentech, Inc. | Predicting response to a her dimerisation inhibitor based on low her3 expression |
US9551033B2 (en) * | 2007-06-08 | 2017-01-24 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
WO2008154249A2 (en) | 2007-06-08 | 2008-12-18 | Genentech, Inc. | Gene expression markers of tumor resistance to her2 inhibitor treatment |
AR067135A1 (es) | 2007-06-22 | 2009-09-30 | Response Genetics Inc | Metodos para aislar arn de fragmento largo de muestras fijas |
BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
ES2572728T3 (es) | 2009-03-20 | 2016-06-02 | F. Hoffmann-La Roche Ag | Anticuerpos anti-HER biespecíficos |
JP5705836B2 (ja) | 2009-05-29 | 2015-04-22 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Her2を発現する胃癌患者のher2シグナル伝達のためのモジュレーター |
US8079170B2 (en) * | 2009-08-28 | 2011-12-20 | Loftin Thomas E | Gun barrel cleaning apparatus and method |
JP5981853B2 (ja) | 2010-02-18 | 2016-08-31 | ジェネンテック, インコーポレイテッド | ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用 |
WO2011146568A1 (en) | 2010-05-19 | 2011-11-24 | Genentech, Inc. | Predicting response to a her inhibitor |
EP2643353A1 (de) | 2010-11-24 | 2013-10-02 | Novartis AG | Multispezifische moleküle |
SG191153A1 (en) | 2010-12-23 | 2013-07-31 | Hoffmann La Roche | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
MX2014001766A (es) | 2011-08-17 | 2014-05-01 | Genentech Inc | Anticuerpos de neuregulina y sus usos. |
WO2013063229A1 (en) | 2011-10-25 | 2013-05-02 | The Regents Of The University Of Michigan | Her2 targeting agent treatment in non-her2-amplified cancers having her2 expressing cancer stem cells |
CA2857114A1 (en) | 2011-11-30 | 2013-06-06 | Genentech, Inc. | Erbb3 mutations in cancer |
WO2013083810A1 (en) | 2011-12-09 | 2013-06-13 | F. Hoffmann-La Roche Ag | Identification of non-responders to her2 inhibitors |
JP2015514710A (ja) | 2012-03-27 | 2015-05-21 | ジェネンテック, インコーポレイテッド | Her3阻害剤に関する診断及び治療 |
MX363188B (es) | 2012-11-30 | 2019-03-13 | Hoffmann La Roche | Identificación de pacientes con necesidad de coterapia del inhibidor de pd-l1. |
EP3454863A1 (de) | 2016-05-10 | 2019-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Kombinationstherapien zur behandlung von krebs |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4830969A (en) * | 1981-08-31 | 1989-05-16 | The Research Foundation Of State University Of New York | Process for the rapid and simple isolation of nucleic acids |
US4843155A (en) * | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
US5128247A (en) * | 1989-08-14 | 1992-07-07 | Board Of Regents, The University Of Texas System | Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources |
US5620852A (en) * | 1990-11-14 | 1997-04-15 | Hri Research, Inc. | Nucleic acid preparation methods |
US5284940A (en) * | 1990-11-14 | 1994-02-08 | Hri Research, Inc. | Preparation for nucleic acid samples |
US5654179A (en) * | 1990-11-14 | 1997-08-05 | Hri Research, Inc. | Nucleic acid preparation methods |
US5346994A (en) * | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
US5502166A (en) * | 1992-02-26 | 1996-03-26 | Mitsubishi Chemical Corporation | NMDH receptor proteins and genes encoding the same |
JP3615545B2 (ja) * | 1993-02-01 | 2005-02-02 | キアゲン・エヌ・ブイ | 第四級アンモニウム塩界面活性剤及びそのrnaの単離剤 |
US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
WO1995028489A1 (en) | 1994-04-13 | 1995-10-26 | The Uab Research Foundation | Dihydropyrimidine dehydrogenase compositions and methods of use |
US5643767A (en) * | 1994-05-02 | 1997-07-01 | The Rockefeller University | Process for isolating cellular components |
CA2153215A1 (en) * | 1994-07-06 | 1996-01-07 | Lu Wang | Treatment of paraffin embedded tissue for gene analysis |
US5856454A (en) | 1994-09-12 | 1999-01-05 | The United States Of America As Represented By The Department Of Health And Human Services | CDNA for human and pig dihydropyrimidine dehydrogenase |
US5707802A (en) * | 1995-01-13 | 1998-01-13 | Ciba Corning Diagnostics Corp. | Nucleic acid probes for the detection and identification of fungi |
US5777099A (en) * | 1995-02-24 | 1998-07-07 | Biotecx Laboratories, Inc. | RNA separation |
US5945515A (en) | 1995-07-31 | 1999-08-31 | Chomczynski; Piotr | Product and process for isolating DNA, RNA and proteins |
DE29601618U1 (de) * | 1996-01-31 | 1996-07-04 | Invitek Gmbh | Vorrichtung zur gleichzeitigen multiplen Isolierung |
EP0791654A1 (de) * | 1996-02-21 | 1997-08-27 | Jürgen A. Dr. Richt | Polypeptide, die Aminosäuresequenzen der p57 oder p9.5 Proteine aus Borna-Krankheit Virus entsprechen, dafür kodierende Nukleinsäurefragmente und ihre Verwendung zu Diagnose- und Immunisierungzwecke |
EP0896629B8 (de) | 1996-03-20 | 2003-01-02 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Verfahren und zusammensetzungen zum nachweis von spleiss-mutationen in dihydropyremudine dehydrogenase |
CA2253937A1 (en) * | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
CA2283636A1 (en) | 1997-03-20 | 1998-09-24 | Variagenics, Inc. | Target genes for allele-specific drugs |
DE19837391A1 (de) | 1997-08-22 | 1999-02-25 | Hoffmann La Roche | Immunologische Materialien und Verfahren zum Nachweis von Dihydropyrimidindehydrogenase |
US5952202A (en) * | 1998-03-26 | 1999-09-14 | The Perkin Elmer Corporation | Methods using exogenous, internal controls and analogue blocks during nucleic acid amplification |
CA2436910C (en) * | 2000-12-01 | 2014-06-17 | Response Genetics, Inc. | Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates |
TWI319010B (en) | 2000-12-01 | 2010-01-01 | Response Genetics Inc | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
-
2001
- 2001-06-13 US US09/879,217 patent/US7005278B2/en not_active Expired - Lifetime
-
2002
- 2002-02-22 MX MXPA03007884A patent/MXPA03007884A/es active IP Right Grant
- 2002-02-22 AU AU2002238115A patent/AU2002238115B2/en not_active Ceased
- 2002-02-22 EP EP02704432A patent/EP1409723B1/de not_active Expired - Lifetime
- 2002-02-22 IL IL15769402A patent/IL157694A0/xx unknown
- 2002-02-22 NZ NZ528374A patent/NZ528374A/en not_active IP Right Cessation
- 2002-02-22 WO PCT/US2002/005221 patent/WO2002070750A2/en active Application Filing
- 2002-02-22 CA CA2439313A patent/CA2439313C/en not_active Expired - Fee Related
- 2002-02-22 AT AT02704432T patent/ATE339521T1/de active
- 2002-02-22 DE DE60214725T patent/DE60214725T2/de not_active Expired - Lifetime
- 2002-02-22 CN CNB028093186A patent/CN1250744C/zh not_active Expired - Fee Related
- 2002-02-22 JP JP2002570772A patent/JP2005508603A/ja not_active Withdrawn
- 2002-02-28 AR ARP020100723A patent/AR032917A1/es active IP Right Grant
- 2002-03-01 TW TW091103764A patent/TWI274076B/zh not_active IP Right Cessation
-
2005
- 2005-01-18 HK HK05100474A patent/HK1068375A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002238115B2 (en) | 2007-06-14 |
TWI274076B (en) | 2007-02-21 |
NZ528374A (en) | 2008-01-31 |
CA2439313C (en) | 2012-08-07 |
JP2005508603A (ja) | 2005-04-07 |
MXPA03007884A (es) | 2004-10-15 |
HK1068375A1 (en) | 2005-04-29 |
US7005278B2 (en) | 2006-02-28 |
EP1409723A2 (de) | 2004-04-21 |
IL157694A0 (en) | 2004-03-28 |
CA2439313A1 (en) | 2002-09-12 |
CN1250744C (zh) | 2006-04-12 |
DE60214725T2 (de) | 2007-09-06 |
US20030165840A1 (en) | 2003-09-04 |
DE60214725D1 (de) | 2006-10-26 |
CN1518603A (zh) | 2004-08-04 |
EP1409723B1 (de) | 2006-09-13 |
WO2002070750A3 (en) | 2004-02-19 |
WO2002070750A2 (en) | 2002-09-12 |
AR032917A1 (es) | 2003-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE339521T1 (de) | Verfahren zur bestimmung der expression des dihydropyrimidindehydrogenasegens | |
DE60120114D1 (de) | Verfahren zur Verbesserung der Knochenmineralisierung | |
DE60045595D1 (de) | Verfahren zur Bestimmung des Gasgehalts | |
DE60210265D1 (de) | Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren | |
DE60307710D1 (de) | Verfahren zur Herstellung von Eisenoxiden | |
DE60232117D1 (de) | Verfahren zur Dickenmessung | |
DE50308659D1 (de) | Verfahren zur kontinuierlichen herstellung von propylenglykolen | |
ATE336597T1 (de) | Verfahren zur gewinnung von gold | |
DE602004021388D1 (de) | Verfahren zur herstellung von cpla 2-inhibitoren | |
DE50311721D1 (de) | Verfahren zur Herstellung von Aryl-aminopropanolen | |
DE50200467D1 (de) | SPM-Sensor und Verfahren zur Herstellung desselben | |
DE50204097D1 (de) | Verfahren zur ermittlung von auswirkungen von konstruktionsentscheidungen | |
DE60301283D1 (de) | Verfahren zur Bestimmung von Biopolymeren | |
DE60137288D1 (de) | Verfahren zur Bestimmung des Basalstoffwechsels | |
DE50304687D1 (de) | Verfahren zur herstellung von benzophenonen | |
DE60113157D1 (de) | Verbessertes verfahren zur herstellung von simvastatin | |
DE60322356D1 (de) | Verfahren zur herstellung von 2-aminoindanderivaten | |
DE60028935D1 (de) | Verfahren zur verminderung des ausleierns des hüftgelenks | |
DE50207028D1 (de) | Verfahren zur bestimmung des enantiomerenverhältnisses von trimethylcyclopenten-derivaten | |
DE60118367D1 (de) | Verfahren zur fluormethylierung von alkoholen | |
FI20000325A0 (fi) | Menetelmä rakenteen rasituksen määrittämiseksi | |
ATE286037T1 (de) | Verfahren zur herstellung von 5-substituierten isobenzofuranen | |
DE50115505D1 (de) | Verfahren zur bestimmung des kritischen pfades einer integrierten schaltung | |
DE60302979D1 (de) | Verfahren zur Herstellung von Epsilon-Caprolactone | |
DE60324881D1 (de) | Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1409723 Country of ref document: EP |